<DOC>
	<DOCNO>NCT02995096</DOCNO>
	<brief_summary>Recurrence liver transplantation hepatocellular carcinoma ( HCC ) represent important cause mortality surgical population . In addition tumor characteristic , It suggest pre-treatment sirolimus-based immunosuppression may affect recurrence survival . With data European Liver Transplant Registry ( ELTR ) database , aim study investigate impact tumor characteristic , pre-transplant treatment immunosuppression regimens survival liver transplantation HCC .</brief_summary>
	<brief_title>Tumor Characteristics , Pre-transplant Treatments Immunosuppression After Liver Transplantation Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Hepatocellular carcinoma within transplantation criterion Disseminated disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>